the latest figures mean that since january 2000, scottish widows has paid a total of £2.5bn in claims to more than 86,000 customers.
.
erenumab (aimovig) is the first of four new migraine drugs in the pipeline that target calcitonin gene-related peptide (cgrp), a molecule that's produced in nerve cells of the
.